TOKYO, Apr 24 (Pulse News Wire) – RaQualia Pharma Inc. (4579.T) completed the subscription payment process for restricted shares granted as compensation to its directors on April 24, 2026.
Details of the issuance were previously disclosed on March 25, 2026. Key points of the share issuance include: - Payment completion date: April 24, 2026 - Type and number of shares issued: Ordinary shares totaling 12,840 - Price per share: ¥795 - Total amount raised: ¥10.2 million The restricted shares were allocated to two directors, excluding audit committee members and outside directors.
This issuance aligns with the resolution passed during the board meeting held on March 25, 2026. For more detailed information, interested parties should refer to the March 25, 2026, press release.
🟡 Confidence: Standard AI-translated content.